Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study

NCT00495820 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

FED

Sponsor class

Conditions

Alzheimer's Disease
Apathy
Dementia

Interventions

DRUG: Methylphenidate
OTHER: Placebo

Sponsor

VA Office of Research and Development